ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
332 hedge funds and large institutions have $6.5B invested in Intra-Cellular Therapies Inc. in 2023 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 108 increasing their positions, 112 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 291 → 332 (+41)
4% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 112
Holders
332
Holding in Top 10
10
Calls
$58.1M
Puts
$27.5M
Top Buyers
| 1 | +$162M | |
| 2 | +$111M | |
| 3 | +$48.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$43.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.7M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$43.7M | |
| 3 | -$43M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$29.6M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$20.4M |